Sort   by:  
 Page size 
UnknownAn Economic Evaluation of the TROG 99.03 Trial: Systemic Therapy After Radiotherapy in Early-Stage Follicular Lymphoma.
Not available
S-EPMC11815322 | biostudies-literature
UnknownA fully dissociated compound of plant origin for inflammatory gene repression.
Not available
S-EPMC1276063 | biostudies-literature
UnknownFrequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma.
Not available
S-EPMC6281423 | biostudies-literature
UnknownAbrogation of glucocorticoid receptor dimerization correlates with dissociated glucocorticoid behavior of compound a.
Not available
S-EPMC2832957 | biostudies-literature
UnknownPolatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma.
Not available
S-EPMC11702892 | biostudies-literature
UnknownIdentification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma.
Not available
S-EPMC7679007 | biostudies-literature
UnknownThe SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network.
Not available
S-EPMC10471929 | biostudies-literature
UnknownEBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity.
Not available
S-EPMC7976507 | biostudies-literature
UnknownManagement and Outcomes of Diffuse Large B-cell Lymphoma Post-transplant Lymphoproliferative Disorder in the Era of PET and Rituximab: A Multicenter Study From the Australasian Lymphoma Alliance.
Not available
S-EPMC8505336 | biostudies-literature
UnknownOutcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance.
Not available
S-EPMC6784528 | biostudies-literature
Sort   by:  
 Page size